BIOMAT Database Logo BIOMAT Database Logo

[Hyperparathyroidism in chronic renal insufficiency]. 1984

I Labos

UI MeSH Term Description Entries
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014807 Vitamin D A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.

Related Publications

I Labos
Chronic renal insufficiency with secondary hyperparathyroidism.
October 1948, Proceedings of the Royal Society of Medicine,
I Labos
Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
January 1991, Mineral and electrolyte metabolism,
I Labos
[Secondary and tertiary hyperparathyroidism and chronic renal insufficiency].
January 1978, Acquisitions medicales recentes,
I Labos
[Secondary hyperparathyroidism prevention in chronic renal insufficiency (author's transl)].
March 1979, Casopis lekaru ceskych,
I Labos
[Surgical treatment of hyperparathyroidism secondary to chronic renal insufficiency].
October 1982, Minerva chirurgica,
I Labos
[Hyperparathyroidism resulting from chronic renal insufficiency. Diagnosis and therapy].
March 1993, Minerva chirurgica,
I Labos
[SECONDARY HYPERPARATHYROIDISM IN RENAL INSUFFICIENCY].
March 1965, Gazette medicale de France,
I Labos
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.
April 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
I Labos
[Radiological aspects of secondary hyperparathyroidism in chronic renal insufficiency (author's transl)].
June 1977, Annales de radiologie,
I Labos
[SECONDARY HYPERPARATHYROIDISM OF RENAL INSUFFICIENCY].
January 1963, Journal d'urologie et de nephrologie,
Copied contents to your clipboard!